JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

4.42 2.79

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.37

Max

4.44

Belangrijke statistieken
By Trading Economics
Inkomsten	1.6M -12M
Verkoop	554K 18M
Winstmarge	-65.968
Werknemers	226
EBITDA	1.6M -9.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+42.57% upside

Dividenden
By Dow Jones
Volgende Winsten	14 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	17M 140M
Vorige openingsprijs	1.63
Vorige sluitingsprijs	4.42

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 mei 2026, 21:36 UTC

Acquisities, Fusies, Overnames

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1 mei 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1 mei 2026, 18:37 UTC

Belangrijke Marktbewegers

Senseonic Shares Slide on Underwritten Offering Price

1 mei 2026, 16:46 UTC

Belangrijke Marktbewegers

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2 mei 2026, 19:57 UTC

Acquisities, Fusies, Overnames

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2 mei 2026, 15:24 UTC

Winsten

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2 mei 2026, 12:46 UTC

Winsten

Acquisities, Fusies, Overnames

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2 mei 2026, 08:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

1 mei 2026, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

1 mei 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 mei 2026, 20:42 UTC

Winsten

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1 mei 2026, 19:33 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

1 mei 2026, 19:33 UTC

Marktinformatie

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1 mei 2026, 19:18 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1 mei 2026, 19:13 UTC

Marktinformatie

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1 mei 2026, 18:36 UTC

Winsten

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1 mei 2026, 18:35 UTC

Winsten

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1 mei 2026, 18:28 UTC

Winsten

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1 mei 2026, 18:27 UTC

Marktinformatie

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1 mei 2026, 18:14 UTC

Acquisities, Fusies, Overnames

Barclays Completes Acquisition of Best Egg

1 mei 2026, 18:04 UTC

Winsten

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1 mei 2026, 17:43 UTC

Marktinformatie

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1 mei 2026, 17:37 UTC

Marktinformatie

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1 mei 2026, 17:30 UTC

Marktinformatie

Winsten

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1 mei 2026, 17:28 UTC

Marktinformatie

Winsten

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1 mei 2026, 17:21 UTC

Marktinformatie

Winsten

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1 mei 2026, 17:19 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1 mei 2026, 16:38 UTC

Marktinformatie

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1 mei 2026, 16:23 UTC

Acquisities, Fusies, Overnames

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1 mei 2026, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

42.57% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.33 USD 42.57%

Hoogste 10 USD

Laagste 3.5 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.